266
R. N. Warrener et al.
Scheme 5.
a complementary approach to these same products but under
different stereocontrolling factors. Such adducts, contain-
ing up to six addressable effector sites (the imide ring, the
N-bridge, and the aromatic ring) retain a norbornene or 7-
substituted norbornene π-bond at the terminus which makes
them suitable for use as BLOCK reagents in the preparation
of functionalized molecular nano-scaffolds.
Experimental
All compounds were characterized by one-dimensional and two-
dimensional nuclear magnetic resonance spectroscopy and high-
resolution mass spectrometry (HRMS). Representative compounds
follow.
Compound (23). mp 191–192◦C; δH (CDCl3) 1.72 (1 H, d, J 9.3),
2.12 (3 H, s), 3.15 (2 H, d, J 9.3), 3.36 (2 H, s), 5.02 (2 H, s), 5.40
(2 H, s), 6.28 (2 H, s), 7.08–7.30 (9 H, m); δC (CDCl3) 24.07, 47.18,
49.78, 65.97, 68.16, 122.50, 123.16, 128.17, 128.80, 129.16, 136.59,
140.84, 156.03, 176.95; HRMS found 426.1572, C26H22N2O4 requires
m/z 426.1579.
Compound (25). Not isolated; δH (CDCl3) 1.44 (3 H, s), 1.61
(3 H, s), 2.16 (3 H, s), 3.81 (1 H, s), 3.84 (1 H, s), 4.94 (1 H, d, J 12.2),
5.03 (1 H, d, J12.2), 5.37 (1 H, s), 5.46 (1 H, s), 6.36 (2 H, s), 7.08–7.36
(9 H, m).
Scheme 6.
described herein, can form dual 1,3-dipolar coupled products
of the nano-scaffold type. As the norbornene blocks can be
coupled stepwise in some procedures, so this opens the way
to produce different nano-scaffold geometries. For example,
nano-scaffold (1) can be accessed through the coupling of
two BLOCKs of type (2) whereas the coupling of (2) with its
isomer (35) would produce the nano-scaffold (36) in which
the two imides (and their effectors) are on opposite sides of
the scaffold frame (Scheme 6).
The additional feature to note in this type of coupling is
the opportunity to introduce additional effector groups at the
R-positions of (1) and (36) thereby allowing edge substitution
of the nano-scaffold.[19]
Compound (28). mp 141–142◦C; δH (CDCl3) 1.46 (1 H, d, J 9.8),
1.68 (1 H, d, J 9.8), 2.26 (3 H, s), 3.31 (1 H, s), 3.35 (1 H, s), 4.91 (1 H,
d, J 12.2), 5.16 (1 H, d, J 12.2), 5.22 (1 H, s), 5.25 (1 H, s), 5.96 (1 H, s),
6.26 (1 H, s), 7.08–7.34 (9 H, m); δC (CDCl3) 24.70, 47.15, 52.11, 62.61,
62.90, 67.65, 122.43, 122.03, 127.98, 128.15, 128.76, 128.91, 129.19,
134.14, 134.91, 137.01, 144.00, 144.47, 152.17, 177.67; HRMS found
426.1576, C26H22N2O4 requires m/z 426.1579.
Compound (29). mp 147–148◦C; δH (CDCl3) 2.32 (3 H, s), 4.91
(1 H, d, J 12), 5.18–5.21 (5 H, m), 6.20 (1 H, d, J 5), 6.54 (1 H, d, J 5),
7.11–7.37(9 H, m);δC (CDCl3)24.80, 60.53, 60.83, 67.66, 68.70, 81.94,
122.00, 122.39, 128.06, 128.63, 128.87, 129.03, 134.56, 134.86, 136.42,
143.43, 143.90, 152.43, 175.96; HRMS found 428.1385, C25H20N2O5
requires m/z 428.1372.
Compound (30). mp 116–119◦C; δH (CDCl3) 1.39 (3 H, s), 1.40
(3 H, s), 2.20 (3 H, s), 3.80 (1 H, s), 3.85 (1 H, s), 4.96 (1 H, d, J 12.2),
5.17 (1 H, d, J 12.2), 5.26 (1 H, s), 5.30 (1 H, s), 6.02 (1 H, s), 6.35
(1 H, s), 7.08–7.36 (9 H, m).
Conclusion
Compound (34). mp 208–209◦C; δH (CDCl3) 2.39 (3 H, s), 3.40
(2 H, s), 4.93 (2 H, s), 5.32 (2 H, s), 6.57 (2 H, s), 7.26–7.32 (5 H, m);
δC (CDCl3) 24.96, 52.96, 67.47, 68.40, 82.11, 126.37, 128.33, 128.89,
129.43, 138.06, 139.43, 146.10, 174.29; HRMS found 456.1099,
C24H16F4N2O3 requires m/z 456.1097.
This paper has demonstrated how norbornene BLOCKs
with multiple addressable sites can be prepared from
N-substituted benzo-7-azanorbornadienenomaleimides in
differing geometrical shapes (path A), e.g. exclusively
extended-frame topology using addition of furan, exclu-
sively bent-frame topology by addition of N-(CO2Bn)-
pyrrole, and mixtures of both with cyclopentadiene or 6,
6-dimethylfulvene. An alternative combination of reagents,
e.g. 7-oxanorbornadienomaleimide with N-substituted isoin-
doles (path B), where the diene carries the benzo ring allows
Acknowledgments
We thank the Australian Research Council for funding this
research and G. S. thanks Central Queensland University for
the award of a Ph.D. scholarship.